Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Lee

Showing results (141-150 of 199) with videos related to

Pageof 20
Sort By:
Epidemiology and Health|October 22, 2024
The prevention and response to infectious diseases in long-term care facilities in Korea: a nationwide surveySun Hee Na, Joong Sik Eom, Sun Bean Kim, et al.
Vaccine|August 29, 2015
Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trialJoon Young Song, Hee Jin Cheong, Jacob Lee, et al.
Vaccine|October 9, 2025
Immunogenicity and safety evaluation of a recombinant protective antigen anthrax vaccine (GC1109): A phase II, dose-confirmed, randomized, double-blind, placebo-controlled studyChang Kyung Kang, Young Jin Im, Dah Yoon Kim, et al.
Plos One|September 17, 2025
Estimating the clinical and economic burden of medically attended influenza in South Korea, stratified by age and comorbidity: A five-season hospital-based surveillance data, 2014/15-2018/19Min Joo Choi, Won Suk Choi, Joon Young Song, et al.
Human Vaccines & Immunotherapeutics|November 2, 2016
Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis: MF59-adjuvanted versus non-adjuvanted vaccinesJi Yun Noh, Joon Young Song, Won Suk Choi, et al.
Emerging Infectious Diseases|August 25, 2021
Policy Review and Modeling Analysis of Mitigation Measures for Coronavirus Disease Epidemic Control, Health System, and Disease Burden, South KoreaHae-Young Kim, In-Hwan Oh, Jacob Lee, et al.
BMC Infectious Diseases|May 7, 2013
Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based studyJoon Young Song, Jun Yong Choi, Jin Soo Lee, et al.
Human Vaccines & Immunotherapeutics|November 7, 2018
Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adultsJoon Young Song, Jacob Lee, Heung Jeong Woo, et al.
Vaccine|December 7, 2016
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adultsJoon Young Song, Hee Jin Cheong, Hak Jun Hyun, et al.
Vaccine|November 2, 2020
Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adultsJoon Young Song, Hye Won Jeong, Jong Woo Yun, et al.
Pageof 20

Showing results (141-150 of 199) with videos related to

Sort By:
Pageof 20
Epidemiology and Health|October 22, 2024
The prevention and response to infectious diseases in long-term care facilities in Korea: a nationwide surveySun Hee Na, Joong Sik Eom, Sun Bean Kim, et al.
Vaccine|August 29, 2015
Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trialJoon Young Song, Hee Jin Cheong, Jacob Lee, et al.
Vaccine|October 9, 2025
Immunogenicity and safety evaluation of a recombinant protective antigen anthrax vaccine (GC1109): A phase II, dose-confirmed, randomized, double-blind, placebo-controlled studyChang Kyung Kang, Young Jin Im, Dah Yoon Kim, et al.
Plos One|September 17, 2025
Estimating the clinical and economic burden of medically attended influenza in South Korea, stratified by age and comorbidity: A five-season hospital-based surveillance data, 2014/15-2018/19Min Joo Choi, Won Suk Choi, Joon Young Song, et al.
Human Vaccines & Immunotherapeutics|November 2, 2016
Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis: MF59-adjuvanted versus non-adjuvanted vaccinesJi Yun Noh, Joon Young Song, Won Suk Choi, et al.
Emerging Infectious Diseases|August 25, 2021
Policy Review and Modeling Analysis of Mitigation Measures for Coronavirus Disease Epidemic Control, Health System, and Disease Burden, South KoreaHae-Young Kim, In-Hwan Oh, Jacob Lee, et al.
BMC Infectious Diseases|May 7, 2013
Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based studyJoon Young Song, Jun Yong Choi, Jin Soo Lee, et al.
Human Vaccines & Immunotherapeutics|November 7, 2018
Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adultsJoon Young Song, Jacob Lee, Heung Jeong Woo, et al.
Vaccine|December 7, 2016
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adultsJoon Young Song, Hee Jin Cheong, Hak Jun Hyun, et al.
Vaccine|November 2, 2020
Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adultsJoon Young Song, Hye Won Jeong, Jong Woo Yun, et al.
Pageof 20